Merete Lundbye Møller

Sunstone Life Science Ventures’ is a European, early-stage investor based in Copenhagen. Sunstone Life Science Ventures invests in drug development opportunities across the European Life Science sector, and prefer to make initial investment in companies raising Series A/B rounds based on solid in-vivo preclinical data and a well understood mechanism of action that fits well into the pathology.